Novel therapies targeting the myeloma cell and its bone marrow microenvironment

被引：168

作者：

Hideshima, T

Chauhan, D

Podar, K

Schlossman, RL

Richardson, P

Anderson, KC

机构：

[1] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Dept Adult Oncol, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 06期

关键词：

D O I：

10.1053/sonc.2001.28608

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：607 / 612

页数：6

共 41 条

[11] High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment [J].

Davies, FE ;

Rollinson, SJ ;

Rawstron, AC ;

Roman, E ;

Richards, S ;

Drayson, M ;

Child, JA ;

Morgan, GJ .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (15) :2843-2851

[12] Proteasome inhibition: A novel mechanism to combat asthma [J].

Elliott, PJ ;

Pien, CS ;

McCormack, TA ;

Chapman, ID ;

Adams, J .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (02) :294-300

[13]

Feinman R, 1999, BLOOD, V93, P3044

[14] PRODUCTION OF LYMPHOTOXIN, A BONE-RESORBING CYTOKINE, BY CULTURED HUMAN MYELOMA CELLS [J].

GARRETT, IR ;

DURIE, BGM ;

NEDWIN, GE ;

GILLESPIE, A ;

BRINGMAN, T ;

SABATINI, M ;

BERTOLINI, DR ;

MUNDY, GR .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (09) :526-532

[15] Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade [J].

Geitz, H ;

Handt, S ;

Zwingenberger, K .

IMMUNOPHARMACOLOGY, 1996, 31 (2-3) :213-221

[16]

GUPTA D, IN PRESS LEUKEMIA

[17] Multiple myeloma: Increasing evidence for a multistep transformation process [J].

Hallek, M ;

Bergsagel, PL ;

Anderson, KC .

BLOOD, 1998, 91 (01) :3-21

[18]

HARBISON MT, 2000, P AM ASSOC CANC RES, V41, P71

[19] Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset [J].

Haslett, PAJ ;

Corral, LG ;

Albert, M ;

Kaplan, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) :1885-1892

[20] Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53 [J].

Herrmann, JL ;

Briones, F ;

Brisbay, S ;

Logothetis, CJ ;

McDonnell, TJ .

ONCOGENE, 1998, 17 (22) :2889-2899

← 1 2 3 4 5 →